ID HPRT_ECOLI Reviewed; 178 AA. AC P0A9M2; P36766; DT 19-JUL-2005, integrated into UniProtKB/Swiss-Prot. DT 19-JUL-2005, sequence version 1. DT 27-MAR-2024, entry version 139. DE RecName: Full=Hypoxanthine phosphoribosyltransferase {ECO:0000303|PubMed:12070315}; DE Short=HPRT {ECO:0000303|PubMed:12070315}; DE EC=2.4.2.8 {ECO:0000269|PubMed:12070315}; DE AltName: Full=6-oxopurine phosphoribosyltransferase {ECO:0000303|PubMed:12070315}; DE Short=6-oxopurine PRTase {ECO:0000303|PubMed:12070315}; GN Name=hpt; OrderedLocusNames=b0125, JW5009; OS Escherichia coli (strain K12). OC Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; OC Enterobacteriaceae; Escherichia. OX NCBI_TaxID=83333; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=8202364; DOI=10.1093/nar/22.9.1637; RA Fujita N., Mori H., Yura T., Ishihama A.; RT "Systematic sequencing of the Escherichia coli genome: analysis of the 2.4- RT 4.1 min (110,917-193,643 bp) region."; RL Nucleic Acids Res. 22:1637-1639(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RX PubMed=9278503; DOI=10.1126/science.277.5331.1453; RA Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V., RA Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F., RA Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B., RA Shao Y.; RT "The complete genome sequence of Escherichia coli K-12."; RL Science 277:1453-1462(1997). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=16738553; DOI=10.1038/msb4100049; RA Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S., RA Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.; RT "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 RT and W3110."; RL Mol. Syst. Biol. 2:E1-E5(2006). RN [4] RP FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION. RX PubMed=23927482; DOI=10.1021/jm400779n; RA Keough D.T., Hockova D., Rejman D., Spacek P., Vrbkova S., Krecmerova M., RA Eng W.S., Jans H., West N.P., Naesens L.M., de Jersey J., Guddat L.W.; RT "Inhibition of the Escherichia coli 6-oxopurine phosphoribosyltransferases RT by nucleoside phosphonates: potential for new antibacterial agents."; RL J. Med. Chem. 56:6967-6984(2013). RN [5] {ECO:0007744|PDB:1G9S, ECO:0007744|PDB:1G9T, ECO:0007744|PDB:1GRV} RP X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEXES WITH IMP; GMP AND RP MAGNESIUM, FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, RP BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, COFACTOR, ACTIVITY REGULATION, RP PATHWAY, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=12070315; DOI=10.1110/ps.0201002; RA Guddat L.W., Vos S., Martin J.L., Keough D.T., de Jersey J.; RT "Crystal structures of free, IMP-, and GMP-bound Escherichia coli RT hypoxanthine phosphoribosyltransferase."; RL Protein Sci. 11:1626-1638(2002). RN [6] {ECO:0007744|PDB:5KNR, ECO:0007744|PDB:5KNS, ECO:0007744|PDB:5KNT, ECO:0007744|PDB:5KNU, ECO:0007744|PDB:5KNV, ECO:0007744|PDB:5KNX} RP X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) IN COMPLEXES WITH NUCLEOSIDE RP PHOSPHONATES INHIBITORS, AND ACTIVITY REGULATION. RX DOI=10.1002/slct.201601679; RA Eng W.S., Hockova D., Spacek P., Baszczynski O., Janeba Z., Naesens L., RA Keough D.T., Guddat L.W.; RT "Crystal Structures of Acyclic Nucleoside Phosphonates in Complex with RT Escherichia coli Hypoxanthine Phosphoribosyltransferase."; RL ChemistrySelect 1:6267-6276(2016). CC -!- FUNCTION: Purine salvage pathway enzyme which catalyzes the transfer of CC the ribosyl-5-phosphate group from 5-phospho-alpha-D-ribose 1- CC diphosphate (PRPP) to the N9 position of hypoxanthine to yield IMP CC (inosine 5'-monophosphate). To a lesser extent, can also act on guanine CC leading to GMP, but shows a highly less efficient activity with CC xanthine. {ECO:0000269|PubMed:12070315}. CC -!- CATALYTIC ACTIVITY: CC Reaction=diphosphate + IMP = 5-phospho-alpha-D-ribose 1-diphosphate + CC hypoxanthine; Xref=Rhea:RHEA:17973, ChEBI:CHEBI:17368, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:58017, ChEBI:CHEBI:58053; EC=2.4.2.8; CC Evidence={ECO:0000269|PubMed:12070315}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:17975; CC Evidence={ECO:0000305|PubMed:12070315}; CC -!- CATALYTIC ACTIVITY: CC Reaction=diphosphate + GMP = 5-phospho-alpha-D-ribose 1-diphosphate + CC guanine; Xref=Rhea:RHEA:25424, ChEBI:CHEBI:16235, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:58017, ChEBI:CHEBI:58115; EC=2.4.2.8; CC Evidence={ECO:0000269|PubMed:12070315}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:25426; CC Evidence={ECO:0000305|PubMed:12070315}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000305|PubMed:12070315}; CC -!- ACTIVITY REGULATION: Inhibited by the product IMP (PubMed:12070315). CC Highly inhibited by nucleoside phosphonates, which are product analogs CC (PubMed:23927482, Ref.6). {ECO:0000269|PubMed:12070315, CC ECO:0000269|PubMed:23927482, ECO:0000269|Ref.6}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=12.5 uM for hypoxanthine (at pH 8.5 and 25 degrees Celsius) CC {ECO:0000269|PubMed:12070315}; CC KM=294 uM for guanine (at pH 8.5 and 25 degrees Celsius) CC {ECO:0000269|PubMed:12070315}; CC KM=25 uM for xanthine (at pH 8.5 and 25 degrees Celsius) CC {ECO:0000269|PubMed:12070315}; CC KM=192 uM for 5-phospho-alpha-D-ribose 1-diphosphate (at pH 8.5 and CC 25 degrees Celsius) {ECO:0000269|PubMed:12070315}; CC Note=kcat is 59.0 sec(-1) with hypoxanthine as substrate. kcat is CC 10.2 sec(-1) with guanine as substrate. kcat is 0.008 sec(-1) with CC xanthine as substrate (at pH 8.5 and 25 degrees Celsius). CC {ECO:0000269|PubMed:12070315}; CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via salvage pathway; IMP CC from hypoxanthine: step 1/1. {ECO:0000305|PubMed:12070315}. CC -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12070315}. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- MISCELLANEOUS: E.coli cells express two distinct 6-oxopurine PRTases, CC with very different specificities for hypoxanthine, guanine, and CC xanthine. Salvage enzymes allow a more energy efficient synthesis of CC purine nucleoside monophosphates compared with the de novo pathway. The CC kinetic analysis suggests that E.coli HPRT is mainly responsible for CC the synthesis of IMP and that XGPRT primarily salvages guanine and CC xanthine. {ECO:0000305|PubMed:12070315}. CC -!- SIMILARITY: Belongs to the purine/pyrimidine phosphoribosyltransferase CC family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U00096; AAC73236.2; -; Genomic_DNA. DR EMBL; AP009048; BAB96700.2; -; Genomic_DNA. DR RefSeq; NP_414667.4; NC_000913.3. DR RefSeq; WP_000683335.1; NZ_STEB01000010.1. DR PDB; 1G9S; X-ray; 2.80 A; A/B=1-178. DR PDB; 1G9T; X-ray; 2.80 A; A/B=1-178. DR PDB; 1GRV; X-ray; 2.90 A; A/B=1-178. DR PDB; 5KNR; X-ray; 2.86 A; A/B=1-178. DR PDB; 5KNS; X-ray; 2.79 A; A/B=1-178. DR PDB; 5KNT; X-ray; 2.55 A; A/B=1-178. DR PDB; 5KNU; X-ray; 2.81 A; A/B=1-178. DR PDB; 5KNV; X-ray; 2.86 A; A/B=1-178. DR PDB; 5KNX; X-ray; 2.40 A; A/B=1-178. DR PDB; 8CAG; X-ray; 2.40 A; A/B=1-176. DR PDBsum; 1G9S; -. DR PDBsum; 1G9T; -. DR PDBsum; 1GRV; -. DR PDBsum; 5KNR; -. DR PDBsum; 5KNS; -. DR PDBsum; 5KNT; -. DR PDBsum; 5KNU; -. DR PDBsum; 5KNV; -. DR PDBsum; 5KNX; -. DR PDBsum; 8CAG; -. DR AlphaFoldDB; P0A9M2; -. DR SMR; P0A9M2; -. DR BioGRID; 4261679; 26. DR BioGRID; 850970; 3. DR DIP; DIP-47994N; -. DR IntAct; P0A9M2; 5. DR STRING; 511145.b0125; -. DR DrugBank; DB04566; Inosinic Acid. DR jPOST; P0A9M2; -. DR PaxDb; 511145-b0125; -. DR EnsemblBacteria; AAC73236; AAC73236; b0125. DR GeneID; 83577940; -. DR GeneID; 946624; -. DR KEGG; ecj:JW5009; -. DR KEGG; eco:b0125; -. DR PATRIC; fig|1411691.4.peg.2157; -. DR EchoBASE; EB4143; -. DR eggNOG; COG0634; Bacteria. DR HOGENOM; CLU_073615_0_0_6; -. DR InParanoid; P0A9M2; -. DR OMA; MQWRVAP; -. DR OrthoDB; 9802824at2; -. DR PhylomeDB; P0A9M2; -. DR BioCyc; EcoCyc:HYPOXANPRIBOSYLTRAN-MONOMER; -. DR BioCyc; MetaCyc:HYPOXANPRIBOSYLTRAN-MONOMER; -. DR BRENDA; 2.4.2.8; 2026. DR UniPathway; UPA00591; UER00648. DR EvolutionaryTrace; P0A9M2; -. DR PRO; PR:P0A9M2; -. DR Proteomes; UP000000318; Chromosome. DR Proteomes; UP000000625; Chromosome. DR GO; GO:0005829; C:cytosol; IDA:EcoCyc. DR GO; GO:0032991; C:protein-containing complex; IDA:EcoCyc. DR GO; GO:0052657; F:guanine phosphoribosyltransferase activity; IDA:EcoCyc. DR GO; GO:0097216; F:guanosine tetraphosphate binding; IDA:EcoCyc. DR GO; GO:0004422; F:hypoxanthine phosphoribosyltransferase activity; IDA:EcoCyc. DR GO; GO:0042802; F:identical protein binding; IPI:EcoCyc. DR GO; GO:0000287; F:magnesium ion binding; IDA:EcoCyc. DR GO; GO:0032263; P:GMP salvage; IDA:EcoliWiki. DR GO; GO:0006178; P:guanine salvage; IBA:GO_Central. DR GO; GO:0046100; P:hypoxanthine metabolic process; IBA:GO_Central. DR GO; GO:0032264; P:IMP salvage; IDA:EcoliWiki. DR GO; GO:0051289; P:protein homotetramerization; IDA:EcoCyc. DR GO; GO:0006166; P:purine ribonucleoside salvage; IEA:UniProtKB-KW. DR CDD; cd06223; PRTases_typeI; 1. DR Gene3D; 3.40.50.2020; -; 1. DR InterPro; IPR005904; Hxn_phspho_trans. DR InterPro; IPR000836; PRibTrfase_dom. DR InterPro; IPR029057; PRTase-like. DR NCBIfam; TIGR01203; HGPRTase; 1. DR PANTHER; PTHR43340:SF1; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; 1. DR PANTHER; PTHR43340; HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; 1. DR Pfam; PF00156; Pribosyltran; 1. DR SUPFAM; SSF53271; PRTase-like; 1. DR PROSITE; PS00103; PUR_PYR_PR_TRANSFER; 1. DR SWISS-2DPAGE; P0A9M2; -. PE 1: Evidence at protein level; KW 3D-structure; Cytoplasm; Glycosyltransferase; Magnesium; Metal-binding; KW Nucleotide-binding; Purine salvage; Reference proteome; Transferase. FT CHAIN 1..178 FT /note="Hypoxanthine phosphoribosyltransferase" FT /id="PRO_0000139632" FT ACT_SITE 103 FT /note="Proton acceptor" FT /evidence="ECO:0000305|PubMed:12070315" FT BINDING 43 FT /ligand="diphosphate" FT /ligand_id="ChEBI:CHEBI:33019" FT /evidence="ECO:0000250|UniProtKB:P9WHQ9" FT BINDING 44 FT /ligand="diphosphate" FT /ligand_id="ChEBI:CHEBI:33019" FT /evidence="ECO:0000250|UniProtKB:P9WHQ9" FT BINDING 99 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1G9T" FT BINDING 99 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1G9S" FT BINDING 99 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1GRV" FT BINDING 100 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1GRV" FT BINDING 103..108 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1G9T" FT BINDING 103..108 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1G9S" FT BINDING 131 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1G9T" FT BINDING 131 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1G9S" FT BINDING 159 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT /evidence="ECO:0000269|PubMed:12070315, FT ECO:0007744|PDB:1G9T" FT BINDING 165 FT /ligand="diphosphate" FT /ligand_id="ChEBI:CHEBI:33019" FT /evidence="ECO:0000250|UniProtKB:P9WHQ9" FT STRAND 3..9 FT /evidence="ECO:0007829|PDB:5KNX" FT HELIX 11..29 FT /evidence="ECO:0007829|PDB:5KNX" FT TURN 30..32 FT /evidence="ECO:0007829|PDB:1G9T" FT STRAND 36..41 FT /evidence="ECO:0007829|PDB:5KNX" FT TURN 42..45 FT /evidence="ECO:0007829|PDB:5KNX" FT HELIX 46..54 FT /evidence="ECO:0007829|PDB:5KNX" FT STRAND 61..67 FT /evidence="ECO:0007829|PDB:5KNX" FT TURN 73..76 FT /evidence="ECO:0007829|PDB:5KNX" FT STRAND 82..84 FT /evidence="ECO:0007829|PDB:5KNX" FT STRAND 93..104 FT /evidence="ECO:0007829|PDB:5KNX" FT HELIX 106..116 FT /evidence="ECO:0007829|PDB:5KNX" FT STRAND 121..130 FT /evidence="ECO:0007829|PDB:5KNX" FT HELIX 132..134 FT /evidence="ECO:0007829|PDB:5KNX" FT STRAND 142..147 FT /evidence="ECO:0007829|PDB:5KNX" FT STRAND 153..155 FT /evidence="ECO:0007829|PDB:5KNX" FT STRAND 160..162 FT /evidence="ECO:0007829|PDB:5KNS" FT STRAND 168..175 FT /evidence="ECO:0007829|PDB:5KNX" SQ SEQUENCE 178 AA; 20115 MW; E1A75EB68231DC32 CRC64; MKHTVEVMIP EAEIKARIAE LGRQITERYK DSGSDMVLVG LLRGSFMFMA DLCREVQVSH EVDFMTASSY GSGMSTTRDV KILKDLDEDI RGKDVLIVED IIDSGNTLSK VREILSLREP KSLAICTLLD KPSRREVNVP VEFIGFSIPD EFVVGYGIDY AQRYRHLPYI GKVILLDE //